CD28 Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (FPT-155, FR-104, Lulizumab Pegol, Others); Application (Plaque Psoriasis, Solid Tumor, Acute Renal Failure (ARF), Others); and Geography

Report Code: TIPRE00021838 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

CD28 is a monoclonal antibody, first discovered in 1981. The antibody plays a major role in cytolytic activity. The protein incorporated by this molecule is important for cytokine production, T-cell proliferation and survival, and T-helper type-2 development.

MARKET DYNAMICS

Rising emphasis on cancer research and development is prominently driving the growth of CD28 Market. In addition, increasing prevalence of cancer and rising investments for cancer research to have positive impact on CD28 Market by 2028. However, lack of infrastructure in emerging countries to hamper the market growth.

MARKET SCOPE

The "CD28 Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of CD28 Market with detailed market segmentation by type and application. The CD28 Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in CD28 Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The CD28 Market is segmented on the basis of type and application. On the basis of type, the market is segmented as FPT-155, FR-104, lulizumab pegol, and others. Based on application, the market is segmented as plaque psoriasis, solid tumor, acute renal failure (ARF), and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the CD28 Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The CD28 Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting CD28 Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the CD28 Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the CD28 Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from CD28 Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the CD28 Market.

The report also includes the profiles of key players in CD28 Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Atox Bio Ltd
  •   Bristol-Myers Squibb Co
  •   Five Prime Therapeutics Inc
  •   Johnson and Johnson
  •   TheraMAB LLC
  •   Boster Bio
  •   Aviva Systems Biology
  •   Biobyt
  •   Genetex
  •   ProteoGenix

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 CD28 Market - By Type
1.3.2 CD28 Market - By Application
1.3.3 CD28 Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CD28 MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CD28 MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CD28 MARKET - GLOBAL MARKET ANALYSIS
6.1. CD28 - GLOBAL MARKET OVERVIEW
6.2. CD28 - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CD28 MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FPT-155
7.3.1. Overview
7.3.2. FPT-155 Market Forecast and Analysis
7.4. FR-104
7.4.1. Overview
7.4.2. FR-104 Market Forecast and Analysis
7.5. LULIZUMAB PEGOL
7.5.1. Overview
7.5.2. Lulizumab Pegol Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. CD28 MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PLAQUE PSORIASIS
8.3.1. Overview
8.3.2. Plaque Psoriasis Market Forecast and Analysis
8.4. SOLID TUMOR
8.4.1. Overview
8.4.2. Solid Tumor Market Forecast and Analysis
8.5. ACUTE RENAL FAILURE (ARF)
8.5.1. Overview
8.5.2. Acute Renal Failure (ARF) Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. CD28 MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America CD28 Market Overview
9.1.2 North America CD28 Market Forecasts and Analysis
9.1.3 North America CD28 Market Forecasts and Analysis - By Type
9.1.4 North America CD28 Market Forecasts and Analysis - By Application
9.1.5 North America CD28 Market Forecasts and Analysis - By Countries
9.1.5.1 United States CD28 Market
9.1.5.1.1 United States CD28 Market by Type
9.1.5.1.2 United States CD28 Market by Application
9.1.5.2 Canada CD28 Market
9.1.5.2.1 Canada CD28 Market by Type
9.1.5.2.2 Canada CD28 Market by Application
9.1.5.3 Mexico CD28 Market
9.1.5.3.1 Mexico CD28 Market by Type
9.1.5.3.2 Mexico CD28 Market by Application
9.2. EUROPE
9.2.1 Europe CD28 Market Overview
9.2.2 Europe CD28 Market Forecasts and Analysis
9.2.3 Europe CD28 Market Forecasts and Analysis - By Type
9.2.4 Europe CD28 Market Forecasts and Analysis - By Application
9.2.5 Europe CD28 Market Forecasts and Analysis - By Countries
9.2.5.1 Germany CD28 Market
9.2.5.1.1 Germany CD28 Market by Type
9.2.5.1.2 Germany CD28 Market by Application
9.2.5.2 France CD28 Market
9.2.5.2.1 France CD28 Market by Type
9.2.5.2.2 France CD28 Market by Application
9.2.5.3 Italy CD28 Market
9.2.5.3.1 Italy CD28 Market by Type
9.2.5.3.2 Italy CD28 Market by Application
9.2.5.4 Spain CD28 Market
9.2.5.4.1 Spain CD28 Market by Type
9.2.5.4.2 Spain CD28 Market by Application
9.2.5.5 United Kingdom CD28 Market
9.2.5.5.1 United Kingdom CD28 Market by Type
9.2.5.5.2 United Kingdom CD28 Market by Application
9.2.5.6 Rest of Europe CD28 Market
9.2.5.6.1 Rest of Europe CD28 Market by Type
9.2.5.6.2 Rest of Europe CD28 Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific CD28 Market Overview
9.3.2 Asia-Pacific CD28 Market Forecasts and Analysis
9.3.3 Asia-Pacific CD28 Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific CD28 Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific CD28 Market Forecasts and Analysis - By Countries
9.3.5.1 Australia CD28 Market
9.3.5.1.1 Australia CD28 Market by Type
9.3.5.1.2 Australia CD28 Market by Application
9.3.5.2 China CD28 Market
9.3.5.2.1 China CD28 Market by Type
9.3.5.2.2 China CD28 Market by Application
9.3.5.3 India CD28 Market
9.3.5.3.1 India CD28 Market by Type
9.3.5.3.2 India CD28 Market by Application
9.3.5.4 Japan CD28 Market
9.3.5.4.1 Japan CD28 Market by Type
9.3.5.4.2 Japan CD28 Market by Application
9.3.5.5 South Korea CD28 Market
9.3.5.5.1 South Korea CD28 Market by Type
9.3.5.5.2 South Korea CD28 Market by Application
9.3.5.6 Rest of Asia-Pacific CD28 Market
9.3.5.6.1 Rest of Asia-Pacific CD28 Market by Type
9.3.5.6.2 Rest of Asia-Pacific CD28 Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa CD28 Market Overview
9.4.2 Middle East and Africa CD28 Market Forecasts and Analysis
9.4.3 Middle East and Africa CD28 Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa CD28 Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa CD28 Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa CD28 Market
9.4.5.1.1 South Africa CD28 Market by Type
9.4.5.1.2 South Africa CD28 Market by Application
9.4.5.2 Saudi Arabia CD28 Market
9.4.5.2.1 Saudi Arabia CD28 Market by Type
9.4.5.2.2 Saudi Arabia CD28 Market by Application
9.4.5.3 U.A.E CD28 Market
9.4.5.3.1 U.A.E CD28 Market by Type
9.4.5.3.2 U.A.E CD28 Market by Application
9.4.5.4 Rest of Middle East and Africa CD28 Market
9.4.5.4.1 Rest of Middle East and Africa CD28 Market by Type
9.4.5.4.2 Rest of Middle East and Africa CD28 Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America CD28 Market Overview
9.5.2 South and Central America CD28 Market Forecasts and Analysis
9.5.3 South and Central America CD28 Market Forecasts and Analysis - By Type
9.5.4 South and Central America CD28 Market Forecasts and Analysis - By Application
9.5.5 South and Central America CD28 Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil CD28 Market
9.5.5.1.1 Brazil CD28 Market by Type
9.5.5.1.2 Brazil CD28 Market by Application
9.5.5.2 Argentina CD28 Market
9.5.5.2.1 Argentina CD28 Market by Type
9.5.5.2.2 Argentina CD28 Market by Application
9.5.5.3 Rest of South and Central America CD28 Market
9.5.5.3.1 Rest of South and Central America CD28 Market by Type
9.5.5.3.2 Rest of South and Central America CD28 Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CD28 MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CD28 MARKET, KEY COMPANY PROFILES
12.1. ATOX BIO LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRISTOL-MYERS SQUIBB CO
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FIVE PRIME THERAPEUTICS INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THERAMAB LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BOSTER BIO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AVIVA SYSTEMS BIOLOGY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOBYT
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENETEX
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PROTEOGENIX
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Atox Bio Ltd
2. Bristol-Myers Squibb Co
3. Five Prime Therapeutics Inc
4. Johnson and Johnson
5. TheraMAB LLC
6. Boster Bio
7. Aviva Systems Biology
8. Biobyt
9. Genetex
10. ProteoGenix
TIPRE00021838
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking